BCLI READ THE FULL BCLI RESEARCH REPORT Business Update Focused on Advancing NurOwn into Phase 3b ENDURANCE Trial BrainStorm ...

SineuGene Therapeutics Co., Ltd. ("SineuGene"), clinical-stage biotechnology company that mainly focuses on gene therapies for neurological disorders, announced today that China's National Medical ...

The rousing biographical drama centred on one of the most renowned figures in science will be leaving Netflix on August 16.

FRIDAY, Aug. 15, 2025 (HealthDay News) — For the first time, scientists have created a brain implant that can “hear” and ...

By Dennis Thompson HealthDay ReporterFRIDAY, Aug. 15, 2025 (HealthDay News) — Breathing problems are common among people with ...

New advances in brain-computer interface (BCI) technology may make speech for those who've lost the ability to do easier than ...

Four people living with severe paralysis, caused by conditions including amyotrophic lateral sclerosis and brainstem stroke, took part in the trial. One participant could only respond ...

After the loss of his mother to ALS, a Kansas City man gave two Chiefs fans who are ALS patients the tour of a lifetime.

Case Western Reserve University scientists have discovered a subset of spinal cord interneurons that boost breathing under ...

Updated data from ongoing open-label Phase 1b trial demonstrated a mean 12-month eGFR of approximately 68 mL/min/1.73 m2 post-transplant for patients on tegoprubart Company on track to report topline ...

Argenx stock catapulted into a breakout in late July, rallying on the back of its "blowout" quarter for a single product: ...

Brainstorm Cell Therapeutics ( ($BCLI) ) has released its Q2 earnings. Here is a breakdown of the information Brainstorm Cell Therapeutics ...